We previously observed that changes in choline phospholipids of two malignant human mammary epithelial cells ( HMECs ) following treatment with a high dose of the cyclooxygenase ( COX ) inhibitor, indomethacin, mimicked changes following transfection with a metastasis suppressor gene, nm23. The similarity between response to indomethacin and nm23 transfection led us to 1 ) expand our 1 H NMR spectroscopy study of indomethacin treatment by determining the response at two doses for two nonmalignant and three malignant HMECs, 2 ) investigate COX -1 and COX -2 levels in HMECs and their relationship with choline phosholipid metabolites, and 3 ) determine changes in Nm23 expression following treatment with indomethacin. All HMECs exhibited a significant change in choline phospholipids following treatment with 300 mM indomethacin. At the lower dose of 50 mM, only nonmalignant HMECs and the estrogen -dependent malignant cell line, MCF -7, responded. COX -1 levels were significantly higher in malignant HMECs than in nonmalignant HMECs. A significant increase in Nm23 expression following 300 mM indomethacin was detected in MCF -12A and MCF -7 cells but not in MDA -MB -231 and MDA -MB -435 cells. These results suggest that COX -1 expression and its inhibition play a role in the choline phospholipid metabolism of HMECs, and the effect of indomethacin on HMECs may be mediated, in part, through upregulation of nm23.
Introduction
Nuclear magnetic resonance spectroscopy has been employed to study choline phospholipid metabolism of breast cancers in vivo, breast cancer cells, and excised tissue. These studies have clearly demonstrated that, compared to normal tissue, the choline phospholipid metabolism of human breast cancer is significantly different [1] [2] [3] [4] .
Our NMR studies of human mammary epithelial cells ( HMECs ) have also revealed distinct alterations in choline phospholipid metabolites of highly malignant breast cancer cells. We observed that nm23 -transfected MDA -MB -435 cells, and transgene tumors derived from these cells, showed significantly lower ratios of phosphorylcholine ( PC ) to glycerophosphorylcholine ( GPC ), compared to vectortransfected control cells and tumors [ 5 ] . Breast cancer studies have shown that low expression levels of nm23 RNA and protein correlate with high metastatic potential [ 6, 7 ] . In vitro experiments using cancer cells transfected with nm23 have also established that nm23 expression alters the motility, invasiveness, and colonization of cancer cells and reduces the metastatic potential of these cells [ 8, 9 ] . Our subsequent studies of the choline phospholipid metabolism of HMECs representing different stages of breast carcinogenesis revealed that the ''malignant phospholipid phenotype'' was characterized by high PC and high total choline [10] . Consistent with our nm23 transfection study, malignant HMECs exhibited higher PC / GPC ratios compared to mortal and immortalized HMECs.
The nonsteroidal anti -inflammatory agent ( NSAID ) and nonspecific cyclooxygenase ( COX ) inhibitor, indomethacin, is known to reduce invasion and metastasis from human breast cancer cells treated with a dose of 50 M for 18 hours [ 11, 12 ] . We observed that, following treatment with a single high dose of 300 M indomethacin, changes in choline phospholipid metabolism of breast cancer cells mimicked the effects of nm23 transfection, and altered the malignant choline phospholipid phenotype toward a less malignant one [ 13 ] . These results suggest that 1 ) the differences in choline phospholipid metabolites between nonmalignant and malignant HMECs may be related, in part, to the inflammatory state of the cell, and 2 ) that nm23 expression may be altered following treatment with indomethacin. Most solid tumors, including breast cancers, exhibit inflammatory properties characterized by increased levels of prostaglandins and other proinflammatory molecules that are secreted by tumor cells, stromal cells, and specialized immune cells during inflammation [ 14, 15 ] . Such an upregulation of inflammatory characteristics is not surprising in view of the similarities between physiological conditions in injured tissue, such as hypoxia and low extracellular pH, and the physiological environment of solid tumors [ 16 -19 ] . The characteristic response of living vascularized tissue to injury is inflammation, which induces the formation of eicosanoids. Three wellknown classes of phospholipases, phospholipase A 2 ( PLA 2 ), phospholipase C, and phospholipase D, participate in the formation of free arachidonate from membrane phospholipids in response to mechanical, chemical, and physical stimuli [ 20 ] . Because arachidonic acid is derived from membrane phospholipids, its production and utilization in the formation of eicosanoids is closely coupled to membrane choline phospholipid metabolism [ 20 ] . Arachidonic acid is converted to various eicosanoids by the action of lipoxygenases and cyclooxygenases [ 21 ] . These eicosanoids impact on cell motility, invasion, vascular characteristics and metastatic dissemination [ 22 -24 ] .
In this study, the relationship between COX -1 and COX -2 levels and choline phosholipid metabolites in untreated and indomethacin treated HMECs was determined. Changes in Nm23 protein expression levels in HMECs following treatment with indomethacin were also determined.
1 H NMR spectroscopy was used to examine the effect of indomethacin on the phospholipid profile of five HMECs: 184 -mortal, a normal mammary epithelial cell line with a finite life span, derived from reduction mammoplasty specimens; MCF -12A, an immortalized, estrogen -independent, but nonmalignant cell line, MCF -7, an estrogen -dependent, malignant cell line, and MDA -MB -231 and MDA -MB -435, two highly malignant, estrogen -independent cell lines. Parallel experiments were performed to determine basal COX -1 and COX -2 expression. Inducible COX expression in these cell lines was also determined by stimulating cells with 12 -Otetradecanoylphorbol -13 -acetate ( TPA ). Expression of Nm23 following the administration of 300 M indomethacin was analyzed using western blotting. All HMECs exhibited a significant change in choline phospholipid metabolites following treatment with 300 M indomethacin. For the lower dose of 50 M, only the nonmalignant cell lines and the estrogen -dependent malignant cell line, MCF -7, displayed a significant change in choline phospholipid metabolites following treatment. MCF -7 is the least aggressive of the three malignant cell lines studied. COX -1, but not COX -2, expression levels were significantly higher in malignant HMECs than in nonmalignant HMECs. A significant increase in Nm23 protein expression was detected in MCF -12A and MCF -7 cells following treatment. Highly malignant and metastatic breast cancer cell lines MDA -MB -435 and MDA -MB -231 did not exhibit a significant increase in Nm23 protein expression. Indomethacin -induced changes in choline compounds of HMECs were found to be cell type and dose dependent. These results suggest that COX activity and its inhibition can alter cell choline phosholipid metabolites, and that the effect of indomethacin treatment of HMECs may be mediated, in part, through upregulation of nm23.
Methods

Cell Lines
The finite life span human mammary epithelial cell line, 184 -mortal, was obtained from Dr. Martha Stampfer ( Lawrence Berkeley National Laboratory, Berkeley, CA ) and cultured in MEBM medium ( Clonetics, Walkersville, MD ) supplemented with growth factors [ 25 ] . The spontaneously immortalized human mammary epithelial cell line MCF -12A, which was established from MCF -12M mortal cells, was obtained from American Type Culture Collection ( ATCC, Rockville, MD ) and cultured in DMEM -Ham's F -12 medium ( Sigma, St. Louis, MO ) supplemented as previously described [ 26 ] . The two human breast cancer cell lines, MDA -MB -231 and MDA -MB -435, originally isolated from pleural effusions of patients with breast carcinoma, were kindly donated by Dr. R. J. Gillies and Dr. J. P. Backer, respectively. The tumor -derived cell lines were cultured in DMEM medium supplemented with 10% fetal bovine serum and antibiotics ( Life Technologies, Grand Island, NY ). MCF -7, an estrogen -sensitive mammary epithelial cancer cell line, was obtained from ATCC and cultured in EMEM medium supplemented with 10% fetal bovine serum and antibiotics [ 27 ] . All media were supplemented with 100 U / ml penicillin and 100 g / ml streptomycin. All cells were maintained at 378C in a humidified atmosphere containing 5% CO 2 .
Extraction and NMR Spectroscopy
To determine the effect of indomethacin treatment on choline phospholipid metabolites, cells were cultured to 70% to 80% confluency at which time they were fed with fresh medium containing 300 M indomethacin ( Sigma ) for 3 hours, or 50 M indomethacin for 18 to 24 hours. Control cells were fed with media without indomethacin at matching times. The cells were harvested and counted using trypan blue exclusion to score for viability. Perchloric acid extracts were obtained from approximately 1Â10 8 cells as previously described [ 10 ] . Briefly, cells were trypsinized, washed twice with cold 150 mM NaCl solution, counted, and homogenized with 5 ml of ice -cold 8% perchloric acid. The homogenates were centrifuged at 15,000 rpm for 15 minutes at 48C and the supernatants neutralized with 3 M K 2 CO 3 -1 M KOH buffer. The samples were again clarified by centrifugation, treated with $50 mg chelex ( Sigma ) to remove divalent ions, lyophilized, and resuspended in 0.6 ml of D 2 O for NMR analysis. Five microliters of D 2 O containing 0.75% 3 -( trimethylsilyl )propionic 2,2,3,3 -d 4 acid sodium salt ( TSP ) was used as an internal standard.
1 H NMR spectra of the extracts were acquired on a 500 -MHz ( 11.7 -T / 89 mm ) MSL Bruker NMR spectrometer ( Bruker, Billerica, MA ) with a 5-mm 1 H probe. NMR spectra were obtained using the following acquisition parameters: 308 flip angle, 6000 Hz sweep width, 4.7 seconds repetition time, 32 K block size, and 128 scans. The small flip angle of the radio frequency pulse and the relatively long interpulse delay efficiently removed saturation effects while preserving high sensitivity of detection. Data were analyzed using Bruker software. PC, GPC, and total choline -containing ( PC + GPC + Cho ) metabolite levels were determined and normalized to cell volume. Cell size was determined for each cell line by trypsinizing the cells and counting the diameter of 50 randomly selected cells using an optical microscope. Between three and nine independent extracts were analyzed for each dose ( 50 and 300 M ) of indomethacin per cell line. To determine metabolite concentrations, peak amplitudes ( I ) for Cho, PC, GPC, and total choline -containing metabolites ( PC + GPC + Cho ) were compared to that of the internal standard TSP according to the equation:
where [ metabolite ] is the molar concentration of the metabolite, A TSP is the number of moles of TSP in the sample, N cell is the cell number, and V cell the cell volume calculated from the radius ( r ) of the cell according to the equation, V cell = 4 / 3r 3 . Peak amplitudes were used because the line widths of the peaks were similar. Corrections for differences in the number of protons were not required, because the number of protons in the choline compounds was the same as the number of protons in TSP. For Eq. ( 1 ) to be valid, it is necessary that spectra are fully relaxed, as in this study, or to correct for saturation. PC / GPC ratios of untreated cells were determined by pooling PC / GPC values of the control sets obtained for both doses ( 50 and 300 M ) of indomethacin.
Western Blotting
Cells were plated and grown on 100 -mm dishes until 80% confluent. To determine basal and inducible levels of the COX enzymes, control cells were fed with fresh medium and TPA -stimulated cells with medium containing 40 nM TPA for 3 hours. Cells were rinsed with phosphate -buffered saline ( 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 Á7H 2 O, 1.4 mM KH 2 PO 4 , pH 7.4 ), scraped, and collected in a lysis buffer containing 100 mM Tris -HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Tween -20, and protease inhibitors ( Boehringer Mannheim, Indianapolis, IN ). Cell lysates were homogenized on ice for 20 seconds. Lysates were centrifuged at 14,000 rpm to sediment particulate material. Protein concentrations were estimated using the Bio -Rad DC assay ( Bio -Rad, Melville, NY ), which is based on the method of Lowry [ 28 ] . Equal amounts of supernatant ( 40 to 100 g protein / lane ) were loaded and resolved on a 10% reducing SDS -PAGE as described by Laemmli [ 29 ] . Proteins were then transferred to an Immobilon -P membrane ( Millipore, Bedford, MA ) according to Towbin [ 30 ] . The uniformity of transfer was verified by staining with Ponceau -S solution ( Sigma ). After blocking in 5% milk overnight, the membrane was separately probed with antibodies to COX -1 ( rabbit polyclonal ) and COX -2 ( rabbit polyclonal ). These antibodies are specific for COX -1 or COX -2 and do not crossreact with each other ( Oxford Biomedical Research, Oxford, MI ). The membrane was then incubated with a horseradish peroxidase -conjugated anti -rabbit antibody ( from donkey ) and the blots were developed using an enhanced chemiluminescence ( ECL ) system ( Amersham Pharmacia Biotech, Piscataway, NJ ) and exposed to Kodak (Rochester, NY) biomax film. Ovine COX -1 and COX -2 were used as standards ( Oxford Biomedical Research, Oxford, MI ). For semiquantitation of COX -1 and COX -2 enzymes, each experiment was repeated thrice under similar experimental conditions. The bands were quantified using NIH -Image 1.61 by comparison with a calibration curve of COX -1 and COX -2 standards loaded on the same gel as the samples. The band intensities were normalized to the total amount of protein loaded in each lane of the gel.
Nm23 expression was analyzed in the presence and absence of indomethacin in MCF -12A, MCF -7, MDA -MB - 231, and MDA -MB -435 cells. Cell lysates were prepared at various time points after treatment with 300 M indomethacin. Total protein ( 40 to 60 g ) was resolved on a 15% SDS -PAGE and then blotted onto a nitrocellulose membrane ( Schleicher & Schuell, Keene, NH ). The membranes were probed with a polyclonal antibody ( Neomarkers, Fremont, CA ) that cross -reacts with both 17 -and 18.5 -kDa isoforms of nm23. After probing for Nm23 protein expression, the membranes were stripped and reprobed with monoclonal anti --actin antibody ( Sigma ). The Nm23 band intensities were normalized to actin. The fold induction was calculated by measuring the increase in Nm23 expression in indomethacin -treated cells compared to corresponding untreated cells ( n = 3 to 5 ).
Statistical Analysis
Data are expressed as mean ± SE. The statistical significance of differences in treatment between untreated and indomethacin -treated cells was determined using the unpaired t test ( two -tailed ). The correlation between total choline levels, PC / GPC ratios and COX -1 levels was examined by Spearman correlation coefficient. P values .05 were considered significant.
Results
The Effect of Indomethacin on the Choline Phospholipid Profiles Representative proton spectra of MCF -7 cells ( A ) untreated, ( B ) treated with 50 M indomethacin for 18 hours, and ( C ) treated with 300 M indomethacin for 3 hours are shown in Figure 1 . Following treatment with indomethacin, GPC levels were elevated, whereas PC levels were reduced. A similar set of spectra from MDA -MB -435 cells ( A ) untreated, ( B ) treated with 50 M indomethacin for 22 hours, and ( C ) treated with 300 M indomethacin for 3 hours are shown in Figure 2 . In contrast to the MCF -7 cells in Figure 1B , MDA -MB -435 cells did not show any change in choline phosholipid metabolites at the low dose of 50 M Figure 2B ) . Data for the fractional decrease in PC / GPC ratio following treatment with 50 and 300 M indomethacin for each cell line are summarized in Figure 3 . A significant decrease of PC / GPC ratios was observed for both malignant and nonmalignant HMECs when treated with 300 M indomethacin for 3 hours. Only MCF -7 cells and the nonmalignant HMECs showed a significant decrease of PC / GPC ratios when treated with 50 M indomethacin for 18 to 24 hours.
COX -1 and COX -2 Expression
Western blots of COX -1 and COX -2 protein expression for the cell lines are shown in Figure 4 The relationship between the amount of total cholinecontaining phospholipids ( PC, GPC, and choline ), PC / GPC ratios, and their corresponding COX -1 levels for the HMECs is illustrated in Figure 5 . A significant positive correlation was observed between PC / GPC ratio and COX -1 expression ( Figure 5A ) as well as between total choline -containing phospholipids ( PC, GPC, and choline ) and COX -1 expression ( Figure 5B ).
Effect of Indomethacin on Nm23 Expression
Basal and indomethacin -induced Nm23 protein ( not isoform specific ) expression for MCF -7 cells is shown in Figure 6A . The nonmalignant immortalized cell line MCF -12A and the estrogen -dependent, malignant cell line MCF -7 expressed higher basal levels of Nm23 compared to the highly malignant cell lines MDA -MB -231 and MDA -MB -435 ( data not shown ). Unlike the highly malignant cell lines, both MCF -12A and MCF -7 cells showed significant induction of Nm23 expression within 1 hour following treatment with 300 M indomethacin as shown in Figure 6B .
Discussion
Elevated COX -1 Expression is Associated with Elevated PC and Total Choline Levels in HMECs
Of the two forms of COX, COX -1 is constitutive and COX -2 is inducible [ 31, 32 ] . Current consensus is that both COX -1 and COX -2 are upregulated for several types of malignant cells and COX -2 is inappropriately induced [ 33, 34 ] . Characterization of COX -1 and COX -2 expression in our study revealed that the malignant HMECs exhibited significantly higher levels of COX -1 expression compared to the nonmalignant normal 184 -mortal cells and immortalized MCF -12A cells. Basal COX -2 expression was variable in the malignant HMECs, as was the inducible expression of COX -2, determined by treating cells with TPA. The expression of inducible COX -2 in 184 -mortal cells was probably due to the presence of growth factors in the medium, which maintain these cells in a stimulated state. Unlike COX -1, neither basal nor inducible COX -2 expression was related to the phospholipid phenotype observed in the cell lines. These results are consistent with other studies which suggest that COX -1 mRNA levels are consistently elevated in breast cancer cells whereas the elevation of COX -2 is variable [ 35 ] . Similar patterns of COX -2 expression for MDA -MB -231 and MDA -MB -435 cells have also been observed by Gilhooly and Rose [ 36 ] .
Our results are also consistent with the study by Hanson and DeLeo [ 37 ] , in which long -wave ultraviolet radiation stimulation of human and mouse fibroblasts led to an increase in the release of PC and, to a lesser extent, GPC. An accompanying elevation of COX, but not lipoxygenase, metabolites was detected. Cancer cells are continually subjected to a stressed environment characterized by hypoxia and extracellular acidosis, both during growth, and during treatment [ 16, 38 ] . Our working hypothesis is that the increased COX -1 expression in malignant cells, compared to nonmalignant cells, may be related to this sustained exposure to stress. Increased COX -1 activity may produce a proportionately higher number of prostanoids that may, in turn, influence the invasive and metastatic behavior [ 22, 23 ] , as well as the vascular characteristics, of the primary and the disseminated tumor [ 39 ] . This sustained stimulation of cells may be responsible for the differences in phospholipid profiles between malignant and nonmalignant HMECs.
In human breast tumors, COX -1 expression has been found to be mainly confined to stroma whereas COX -2 expression was detected within tumor cells and occasionally in stromal cells [ 40 ] . This differential expression of COX -1 and COX -2 within a tumor suggests that both autocrine and paracrine mechanisms may be responsible for the development of the tumor type. Depending on the stimuli, either COX -1, or COX -2, or both enzymes may be overexpressed. Alternatively, the expression of one COX isoform may influence the expression of the other isoform. Narko et al. [ 41 ] have shown that COX -1 can solely contribute to the tumorigenicity of a cell type. Transfection of ECV -304, a spontaneously transformed endothelial cell line, with COX -1, resulted in the formation of tumors in athymic mice. In addition, experiments using Min ( multiple intestinal neoplasia ) mice have demonstrated that Min mice deficient in either COX -1 or COX -2 genes show a decreased incidence of intestinal tumorigenesis suggesting that both enzymes play a role in promoting tumorigenesis [ 42, 43 ] .
Although we have only examined COX -1 and COX -2 expression in this study, the impact of other enzymes of the choline cycle on the cellular choline phospholipid profile should also be considered. For instance, increased choline kinase activity has been observed in patients with colon carcinoma [ 44 ] , and elevated PLA 2 levels have been detected in the serum of patients with cancer [ 45 ] as well as in ras -transformed HMECs [ 46 ] . An increase in lipoxygenase products has also been detected in patients with breast cancer [ 15 ] . Preliminary data from other groups suggest that activation of phospholipases by growth factors and oncogene products could result in high constitutive intracellular pools of PC within these cells [ 47 -49 ] . These observations suggest that changes in activity, expression, and synthesis of enzymes that influence the inflammatory pathway also affect choline phosholipid metabolites.
Effect of Indomethacin on the Choline Phospholipid Profile of HMECs
The PC / GPC ratio decreased significantly following treatment with indomethacin. Of the three malignant cell lines, MCF -7 cells were the most sensitive, exhibiting a significant decrease of PC / GPC ratio for the 50 M dose, which was not observed for MDA -MB -231 and MDA -MB -435 cells. The nonmalignant cell lines were more sensitive than the malignant cell lines to indomethacin, exhibiting a further reduction in PC following treatment. As mentioned earlier, changes in NMR spectra of the malignant HMECs following treatment with indomethacin were very similar to changes observed in MDA -MB -435 cells following transfection with nm23 [ 5 ] and were characteristic of a decreased malignant phenotype.
Changes in choline phospholipids have been observed during tumor progression, in immortalized or oncogene transformed cell lines, and during drug therapy [ 50 -52 ] . Comparison of 31 P NMR spectra from a normal breast epithelial cell strain ( 76N ) with three breast cancer cell lines ( 21PT, 21NT and 21MT -2 ) established from the same patient, showed that PC levels were significantly higher in the breast cancer cell lines [ 50 ] . These changes were reflected as a significant decrease in the GPC / PC ratios in the primary ( 21PT, 21NT ) and metastatic tumor ( 21MT -2 ) cell lines when compared with the normal cell strain. 21MT -2, the metastatic cell line, also showed a significant decrease in GPC / PC ratio compared with the primary breast cell lines, 21PT and 21NT. Similarly, a high PC / GPC ratio was observed for a series of human tumor lines of neuronal origin when compared with primary cultures of the central and peripheral nervous system or to normal tissue obtained from brain biopsy extracts [ 51 ] . Thus, malignant transformation is accompanied with an increased PC / GPC ratio. Conversely, growth arrest has been shown to reduce the PC / GPC ratio. Treatment of MCF -7 cells with tumor necrosis factor -alpha, which induces cell cycle arrest and apoptosis, resulted in a decrease of PC [ 52 ] . An increase in GPC was observed when rat Schwann cells were transformed by H -ras, which causes growth arrest in these cells [ 51 ] . In addition to COX inhibition, indomethacin has been observed to induce cell cycle arrest [ 53, 54 ] , apoptosis [ 55, 56 ] , and potentiate the effects of differentiating agents [ 57 ] . These effects have been shown to occur either through, or independently of, the COX pathway [ 58 ] , but are consistent with the changes in PC / GPC observed in the spectra. Although we did not observe significant changes in cell viability using trypan blue exclusion following treatment with indomethacin, further experiments are currently underway to determine the effect of indomethacin on cell cycle arrest and apoptosis for our panel of HMECs.
Effect of Indomethacin on Nm23 Expression in HMECs
Nm23 proteins, also known as nucleoside diphosphate kinases, are phosphotransferases that are implicated in cell growth and differentiation [ 59 ] . Here we have shown that in HMECs, indomethacin enhances the expression of Nm23, which is also a metastasis suppressor protein [ 7 ] . Induction of Nm23 expression by indomethacin is consistent with the phospholipid changes seen in HMECs following treatment with indomethacin. The two cell lines, MCF -12A and MCF -7, which were most sensitive to indomethacin treatment, as indicated by a significant change in their phospholipid profiles, also showed a significant increase in Nm23 expression. Other studies have shown that Nm23 expression is downregulated in the presence of proinflammatory molecules such as PGE 2 , tumor necrosis factor -alpha, and interferon -gamma in B16 -F10 murine melanoma cells [ 60 ] . Inflammatory responses and metastasis suppressor protein expression may be linked through an Nm23 -mediated phospholipid signaling pathway [ 61 ] .
In conclusion, as outlined in the schematic in Figure 7 , the significant relationship observed between the PC / GPC ratio obtained from 1 H NMR spectra of breast cancer cells and their COX -1 expression, and the decrease in PC / GPC ratio following indomethacin treatment, suggests that both the initial phospholipid profiles, as well as changes observed following treatment with indomethacin may be related to COX activity and Nm23 expression. The precise mechanisms underlying the increase in GPC relative to PC following treatment with indomethacin are yet to be delineated. Indomethacin is used to treat rheumatoid arthritis, with daily doses of 100 to 150 mg given over a period of 4 to 6 weeks [ 62, 63 ] . These doses are comparable with the concentrations of 50 to 300 M used in our study. Our NMR data, and the enhanced expression of Nm23 following indomethacin, support further investigations of NSAIDs in cancer therapy for chemoprevention and for the treatment of metastatic disease. Further studies are also necessary to understand mechanisms by which antiinflammatory agents impact metastasis suppressor pathways and the role of oncogenes in activating inflammatory pathways.
